Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

239,842 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models.
Li D, Geng K, Hao Y, Gu J, Kumar S, Olson AT, Kuismi CC, Kim HM, Pan Y, Sherman F, Williams AM, Li Y, Li F, Chen T, Thakurdin C, Ranieri M, Meynardie M, Levin DS, Stephens J, Chafitz A, Chen J, Donald-Paladino MS, Powell JM, Zhang ZY, Chen W, Ploszaj M, Han H, Gu S, Zhang T, Hu B, Nacev BA, Kaiza ME, Berger AH, Wang X, Li J, Sun X, Liu Y, Zhang X, Bruno TC, Gray NS, Nabet B, Wong KK, Zhang H. Li D, et al. Among authors: li f, li y, li j. J Clin Invest. 2024 Dec 24:e174249. doi: 10.1172/JCI174249. Online ahead of print. J Clin Invest. 2024. PMID: 39718828 Free article.
Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer.
Lee S, Cho Y, Li Y, Li R, Brown D, McAuliffe P, Lee AV, Oesterreich S, Zervantonakis IK, Osmanbeyoglu HU. Lee S, et al. Among authors: li y, li r. bioRxiv [Preprint]. 2024 Mar 26:2024.03.21.586041. doi: 10.1101/2024.03.21.586041. bioRxiv. 2024. Update in: Oncoimmunology. 2024 Dec 31;13(1):2429186. doi: 10.1080/2162402X.2024.2429186 PMID: 38585952 Free PMC article. Updated. Preprint.
Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer.
Lee S, Cho Y, Li Y, Li R, Lau AW, Laird MS, Brown D, McAuliffe P, Lee AV, Oesterreich S, Zervantonakis IK, Osmanbeyoglu HU. Lee S, et al. Among authors: li y, li r. Oncoimmunology. 2024 Dec 31;13(1):2429186. doi: 10.1080/2162402X.2024.2429186. Epub 2024 Nov 26. Oncoimmunology. 2024. PMID: 39587886 Free PMC article.
239,842 results
You have reached the last available page of results. Please see the User Guide for more information.